French and Slovene Pharmaceutical Companies Found Joint Venture
Ljubljana, 9 September - PHARMACEUTICAL/INDUSTRY/LEK/SANOFI-SYNTHELABO
France's Sanofi-Synthelabo and Slovenia's Lek have established a new joint venture which will market and sell Sanofi-Synthelabo's products, including aprovel and plavix.
The rest of this news item is available to subscribers.
The news item consists of 477 characters (without spaces) or 86 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.